Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
President Donald Trump has consistently demonstrated a preference for maintaining control over escalation rather than allowing events to dictate American strategy.
The rise of transactional unilateral diplomacy—most visibly associated with U.S. President Donald Trump—has exposed structural vulnerabilities in the alliance system.